KR880012231A - 스테로이드의 용도 - Google Patents

스테로이드의 용도 Download PDF

Info

Publication number
KR880012231A
KR880012231A KR1019880004177A KR880004177A KR880012231A KR 880012231 A KR880012231 A KR 880012231A KR 1019880004177 A KR1019880004177 A KR 1019880004177A KR 880004177 A KR880004177 A KR 880004177A KR 880012231 A KR880012231 A KR 880012231A
Authority
KR
South Korea
Prior art keywords
cholesteryl
pharmaceutically acceptable
phosphoryl choline
acceptable salts
atherosclerosis
Prior art date
Application number
KR1019880004177A
Other languages
English (en)
Inventor
마리 카잘 쟝
랭스팰트 한스
Original Assignee
장 자크 오가이 프리돌린 클라우스나
에프.호프만-라 로슈 앤드 캄파니 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 장 자크 오가이 프리돌린 클라우스나, 에프.호프만-라 로슈 앤드 캄파니 아크티엔게젤샤프트 filed Critical 장 자크 오가이 프리돌린 클라우스나
Publication of KR880012231A publication Critical patent/KR880012231A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음

Description

스테로이드의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 약제학적 활성물질, 특히 클레스테롤 흡수를 억제하고 혈장 콜레스테롤을 저하시키는 활성물질인 콜레스테릴-포스포릴 콜린 및 약제학적으로 허용되는 이의 염.
  2. 특히 콜레스테롤 흡수를 억제하고 혈장 콜레스테롤을 저하시키기 위한 콜레스테릴-포스포릴 콜린 또는 약제학적으로 허용되는 이의 염을 함유하는 약제.
  3. 질병, 특히 고콜레스테롤혈증 및 아테롬선 동맥 경화증 억제 또는 예방에 있어서 콜레스테릴-포스포릴 콜린 및 약제학적으로 허용되는 이의 염의 용도.
  4. 질병, 특히 고콜레스테롤혈증 및 아테롬성 동맥 경화증 억제 또는 예방하기 위한 약제 제조용 콜레스테릴-포스포릴 콜린 및 약제학적으로 허용되는 이의 염의 용도.
    ※ 참고사항 : 최초출원내용에 의하여 공개하는 것임.
KR1019880004177A 1987-04-15 1988-04-13 스테로이드의 용도 KR880012231A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH148087 1987-04-15
CH1480/87 1987-04-15

Publications (1)

Publication Number Publication Date
KR880012231A true KR880012231A (ko) 1988-11-26

Family

ID=4211456

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880004177A KR880012231A (ko) 1987-04-15 1988-04-13 스테로이드의 용도

Country Status (10)

Country Link
EP (1) EP0287014A3 (ko)
JP (1) JPS63277695A (ko)
KR (1) KR880012231A (ko)
AU (1) AU1447388A (ko)
DK (1) DK193688A (ko)
HU (1) HUT47023A (ko)
IL (1) IL86030A0 (ko)
MC (1) MC1922A1 (ko)
PT (1) PT87245B (ko)
ZA (1) ZA882479B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215972A (en) * 1989-11-22 1993-06-01 Hoffmann-La Roche Inc. Steroids

Also Published As

Publication number Publication date
MC1922A1 (fr) 1989-04-06
AU1447388A (en) 1988-10-20
ZA882479B (en) 1988-10-17
PT87245A (pt) 1988-05-01
EP0287014A2 (de) 1988-10-19
IL86030A0 (en) 1988-09-30
PT87245B (pt) 1992-08-31
DK193688A (da) 1988-10-16
EP0287014A3 (de) 1990-06-06
DK193688D0 (da) 1988-04-08
HUT47023A (en) 1989-01-30
JPS63277695A (ja) 1988-11-15

Similar Documents

Publication Publication Date Title
BR0013704A (pt) Uso de inibidores do sistema renina-angiotensina na prevenção de casos cardiovasculares
NO924502D0 (no) Ny anvendelse av difenylbutyl-piperazinkarboksamider ved behandling av stoffmisbruklidelser
ES2058725T3 (es) Aplicacion transdermica de 2-amino-6-n-propilamino-4,5,6,7-tetrahidrobenzotiazol.
KR940006578A (ko) 2-(3,4-디메톡신나모일) 아미노벤조산
KR890000101A (ko) 반월조직의 치료 개선방법 및 치료약제
KR950016744A (ko) 트롬빈을 저해하는 방법
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
EP0648492A3 (en) Inhibition of phosphatidylinositol-3-kinase with viridin, dimethoxyviridin, viridiol, dimethoxyviridiol, virone, wortmannolone, and their derivatives.
CA2040865A1 (en) Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor
GR3004150T3 (en) Medicaments for the treatment or prevention of the withdrawal syndrome.
KR890012644A (ko) 간 장해 치료제
KR890001564A (ko) 약학적 투여 단위
KR910007509A (ko) 친유성 약제용 주사 조성물
RU94045866A (ru) Применение бисфенилалкилпиперазинов для лечения расстройств, вызванных злоупотреблением веществами, способ лечения
KR920016094A (ko) 전혈청 콜레스테롤, ldl 콜레스테롤 및 트리글리세라이드를 저하시키기 위한 테니다프를 함유하는 제약 조성물
ZA952058B (en) Use of compounds having an anti-glucocorticoid activity for the preparation of medicaments intended for the prevention or treatment of symptoms associated with the syndrome of spontaneous or precipitated withdrawal from narcotics or narcotic mixtures and the compositions containing them
KR880012231A (ko) 스테로이드의 용도
ES2176702T3 (es) Antimicoticos con alta liberacion de sustancia activa.
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose
HUP9901990A3 (en) Furan- and thiophene derivatives having inhibitor effect on the replication of hiv-1 and hiv-1 mutants, and medicaments containing the same
NO990450L (no) Behandling av sinnslidelser
BR9707770C1 (pt) Tifluzamida com eficácia aperfeiçoada
ATE207357T1 (de) Verwendung von cotinin zur linderung des tabakentzugssyndrom
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
ATE169922T1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid